Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 657

1.

Antiproliferative potential from aqueous Viscum album L. preparations and their main constituents in comparison with ricin and purothionin on human cancer cells.

Felenda JE, Turek C, Stintzing FC.

J Ethnopharmacol. 2019 Mar 3;236:100-107. doi: 10.1016/j.jep.2019.02.047. [Epub ahead of print]

PMID:
30840914
2.

Radioprotective effects of Mistletoe extract in Zebrafish embryos in vivo.

Rim CH, Koun S, Park HC, Lee S, Kim CY.

Int J Radiat Biol. 2019 Mar 5:1-23. doi: 10.1080/09553002.2019.1590661. [Epub ahead of print]

PMID:
30836032
3.

Prolonged stabilization of platinum-refractory ovarian cancer in a single patient undergoing long-term Mistletoe extract treatment: Case report.

Hwang WY, Kang MH, Lee SK, Yeom JS, Jung MH.

Medicine (Baltimore). 2019 Feb;98(8):e14536. doi: 10.1097/MD.0000000000014536.

4.

Use and Safety of Viscum album L Applications in Cancer Patients With Preexisting Autoimmune Diseases: Findings From the Network Oncology Study.

Oei SL, Thronicke A, Kröz M, Matthes H, Schad F.

Integr Cancer Ther. 2019 Jan-Dec;18:1534735419832367. doi: 10.1177/1534735419832367.

PMID:
30808274
5.

Do recent research studies validate the medicinal plants used in British Columbia, Canada for immune-mediated and other problems in pets?

Lans C.

J Ethnopharmacol. 2019 Feb 14. pii: S0378-8741(18)30839-0. doi: 10.1016/j.jep.2019.02.030. [Epub ahead of print]

PMID:
30772483
6.

Mistletoe in oncological treatment: a systematic review : Part 1: survival and safety.

Freuding M, Keinki C, Micke O, Buentzel J, Huebner J.

J Cancer Res Clin Oncol. 2019 Mar;145(3):695-707. doi: 10.1007/s00432-018-02837-4. Epub 2019 Jan 23. Review.

PMID:
30673873
7.

Mistletoe in oncological treatment: a systematic review : Part 2: quality of life and toxicity of cancer treatment.

Freuding M, Keinki C, Kutschan S, Micke O, Buentzel J, Huebner J.

J Cancer Res Clin Oncol. 2019 Jan 23. doi: 10.1007/s00432-018-02838-3. [Epub ahead of print] Review.

PMID:
30673872
8.

Absence of herb-drug interactions of mistletoe with the tamoxifen metabolite (E/Z)-endoxifen and cytochrome P450 3A4/5 and 2D6 in vitro.

Weissenstein U, Kunz M, Oufir M, Wang JT, Hamburger M, Urech K, Regueiro U, Baumgartner S.

BMC Complement Altern Med. 2019 Jan 18;19(1):23. doi: 10.1186/s12906-019-2439-2.

10.

Intralesional and subcutaneous application of Viscum album L. (European mistletoe) extract in cervical carcinoma in situ: A CARE compliant case report.

Reynel M, Villegas Y, Kiene H, Werthmann PG, Kienle GS.

Medicine (Baltimore). 2018 Nov;97(48):e13420. doi: 10.1097/MD.0000000000013420.

11.

Mistletoe Extracts (PDQ®): Health Professional Version.

PDQ Integrative, Alternative, and Complementary Therapies Editorial Board.

PDQ Cancer Information Summaries [Internet]. Bethesda (MD): National Cancer Institute (US); 2002-.
2018 Oct 5.

12.

Use of biologically-based complementary medicine in breast and gynecological cancer patients during systemic therapy.

Drozdoff L, Klein E, Kiechle M, Paepke D.

BMC Complement Altern Med. 2018 Sep 24;18(1):259. doi: 10.1186/s12906-018-2325-3.

13.

Complementary Treatment with Mistletoe Extracts During Chemotherapy: Safety, Neutropenia, Fever, and Quality of Life Assessed in a Randomized Study.

Pelzer F, Tröger W, Nat DR.

J Altern Complement Med. 2018 Sep/Oct;24(9-10):954-961. doi: 10.1089/acm.2018.0159.

14.

Adjuvant Therapy Using Mistletoe Containing Drugs Boosts the T-Cell-Mediated Killing of Glioma Cells and Prolongs the Survival of Glioma Bearing Mice.

Schötterl S, Huber SM, Lentzen H, Mittelbronn M, Naumann U.

Evid Based Complement Alternat Med. 2018 Aug 27;2018:3928572. doi: 10.1155/2018/3928572. eCollection 2018.

15.

Thermosensitive liposomes for triggered release of cytotoxic proteins.

de Matos MBC, Beztsinna N, Heyder C, Fens MHAM, Mastrobattista E, Schiffelers RM, Leneweit G, Kok RJ.

Eur J Pharm Biopharm. 2018 Nov;132:211-221. doi: 10.1016/j.ejpb.2018.09.010. Epub 2018 Sep 14.

16.

Safety of high-dose intravenous mistletoe therapy in pediatric cancer patients: A case series.

Zuzak TJ, Wasmuth A, Bernitzki S, Schwermer M, Längler A.

Complement Ther Med. 2018 Oct;40:198-202. doi: 10.1016/j.ctim.2018.01.002. Epub 2018 Jan 11.

PMID:
30219449
17.

Taraxacum officinale extract shows antitumor effects on pediatric cancer cells and enhance mistletoe therapy.

Menke K, Schwermer M, Felenda J, Beckmann C, Stintzing F, Schramm A, Zuzak TJ.

Complement Ther Med. 2018 Oct;40:158-164. doi: 10.1016/j.ctim.2018.03.005. Epub 2018 Mar 13.

PMID:
30219442
18.

Integrative cancer care in a certified Cancer Centre of a German Anthroposophic hospital.

Thronicke A, Oei SL, Merkle A, Herbstreit C, Lemmens HP, Grah C, Kröz M, Matthes H, Schad F.

Complement Ther Med. 2018 Oct;40:151-157. doi: 10.1016/j.ctim.2018.03.012. Epub 2018 Apr 4.

19.

Efficacy and safety of Viscum album extract (Helixor-M) to treat malignant pleural effusion in patients with lung cancer.

Lee YG, Jung I, Koo DH, Kang DY, Oh TY, Oh S, Lee SS.

Support Care Cancer. 2018 Sep 14. doi: 10.1007/s00520-018-4455-z. [Epub ahead of print]

PMID:
30218188
20.

Clinical Safety of Combined Targeted and Viscum album L. Therapy in Oncological Patients.

Thronicke A, Oei SL, Merkle A, Matthes H, Schad F.

Medicines (Basel). 2018 Sep 6;5(3). pii: E100. doi: 10.3390/medicines5030100.

Supplemental Content

Loading ...
Support Center